FollowMyHealth Patient Portal

Erik Richard Dubberke, MD

Associate Professor, Medicine
Division of Infectious Diseases

Specialty Areas

Infectious Diseases
Oncology

Board Certifications

Internal Medicine
Infectious Diseases

Hospital Affiliations

Barnes-Jewish Hospital
VA Medical Center - St. Louis - John Cochran Division

Areas of Clinical Interest

Infectious diseases, C. difficile infection, fungal infections, infections in transplant patients,  infections in cancer patients

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Taylor Ave. Building Extension

620 South Taylor Ave.
Suite 100
St. Louis, MO 63110

Office Phone: 314-747-1206
Fax: 314-222-6252

Education

Education

Residency: Washington University School of Medicine, St. Louis, Missouri 2002
Medical Degree: University of Illinois at Chicago College of Medicine, Rockford, Illinois 1999
B.A.: Augustana College, Rock Island, Illinois 1995

Publication & Research

Publication & Research

The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases.
Olsen MA, Young-Xu Y, Stwalley D, Kelly CP, Gerding DN, Saeed MJ, Mahé C, Dubberke ER
BMC Infect Dis. 2016 Apr 22; 16(1)177. doi: 10.1186/s12879-016-1501-7.

PMID:
    27102582
    [PubMed - in process]
Related citations


Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings.
Durham DP, Olsen MA, Dubberke ER, Galvani AP, Townsend JP
Emerg Infect Dis. 2016 Apr; 22(4)608-16. doi: 10.3201/eid2204.150455.

PMID:
    26982504
    [PubMed - in process]
Related citations


Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis.
Dubberke ER, Olsen MA, Stwalley D, Kelly CP, Gerding DN, Young-Xu Y, Mahé C
PLoS One. 2016; 11(2)e0146822. doi: 10.1371/journal.pone.0146822.

PMID:
    26859403
    [PubMed - in process]
Related citations


Clostridium difficile-Diagnostic and Clinical Challenges.
Burnham CA, Dubberke ER, Kociolek LK, Polage CR, Riley TV
Clin Chem. 2016 Feb; 62(2)310-4. doi: 10.1373/clinchem.2015.243717.

PMID:
    26656133
    [PubMed - in process]
Related citations


Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study.
Orenstein R, Dubberke E, Hardi R, Ray A, Mullane K, Pardi DS, Ramesh MS, PUNCH CD Investigators
Clin Infect Dis. 2016 Mar 1; 62(5)596-602. doi: 10.1093/cid/civ938.

PMID:
    26565008
    [PubMed - in process]
Related citations


Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.
Young JA, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Dubberke ER, Pergam SA, Marty FM, Strasfeld LM, Brown JW, Langston AA, Schuster MG, Kaul DR, Martin SI, Anasetti C, Blood and Marrow Transplant Clinical Trials Network Trial 0201
Biol Blood Marrow Transplant. 2016 Feb; 22(2)359-70. doi: 10.1016/j.bbmt.2015.09.013.

PMID:
    26409243
    [PubMed - in process]
Related citations


Diagnosis of Clostridium difficile Infection: Treat the Patient, Not the Test.
Dubberke ER, Burnham CA
JAMA Intern Med. 2015 Nov; 175(11)1801-2. doi: 10.1001/jamainternmed.2015.4607.

PMID:
    26348248
    [PubMed - indexed for MEDLINE]
Related citations


Randomized Controlled Trial to Determine the Impact of Probiotic Administration on Colonization With Multidrug-Resistant Organisms in Critically Ill Patients.
Kwon JH, Bommarito KM, Reske KA, Seiler SM, Hink T, Babcock HM, Kollef MH, Fraser VJ, Burnham CA, Dubberke ER, Centers for Disease Control and Prevention (CDC) Prevention Epicenters
Infect Control Hosp Epidemiol. 2015 Dec; 36(12)1451-4. doi: 10.1017/ice.2015.195.

PMID:
    26308946
    [PubMed - in process]
Related citations


Ceftolozane-tazobactam activity against phylogenetically diverse Clostridium difficile strains.
Gonzalez MD, Wallace MA, Hink T, Dubberke ER, Burnham CA
Antimicrob Agents Chemother. 2015 Nov; 59(11)7084-5. doi: 10.1128/AAC.01670-15.

PMID:
    26282409
    [PubMed - in process]
Related citations


The Importance of Colonization with Clostridium difficile on Infection and Transmission.
Morgan DJ, Leekha S, Croft L, Burnham CA, Johnson JK, Pineles L, Harris AD, Dubberke ER
Curr Infect Dis Rep. 2015 Sep; 17(9)499. doi: 10.1007/s11908-015-0499-0.

PMID:
    26239132
    [PubMed]
Related citations


Clostridium difficile Infection Among Veterans Health Administration Patients.
Young-Xu Y, Kuntz JL, Gerding DN, Neily J, Mills P, Dubberke ER, Olsen MA, Kelly CP, Mahé C
Infect Control Hosp Epidemiol. 2015 Sep; 36(9)1038-45. doi: 10.1017/ice.2015.138.

PMID:
    26047207
    [PubMed - in process]
Related citations


Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients.
Dubberke ER, Reske KA, Seiler S, Hink T, Kwon JH, Burnham CA
Antimicrob Agents Chemother. 2015 Aug; 59(8)4533-43. doi: 10.1128/AAC.00642-15.

PMID:
    25987626
    [PubMed - indexed for MEDLINE]
Related citations


Clostridium Difficile Infection in the United States: A National Study Assessing Preventive Practices Used and Perceptions of Practice Evidence.
Saint S, Fowler KE, Krein SL, Ratz D, Flanders SA, Dubberke ER, Greene MT
Infect Control Hosp Epidemiol. 2015 Aug; 36(8)969-71. doi: 10.1017/ice.2015.81.

PMID:
    25896321
    [PubMed - indexed for MEDLINE]
Related citations


Procedure-specific surgical site infection incidence varies widely within certain National Healthcare Safety Network surgery groups.
Saeed MJ, Dubberke ER, Fraser VJ, Olsen MA
Am J Infect Control. 2015 Jun; 43(6)617-23. doi: 10.1016/j.ajic.2015.02.012.

PMID:
    25818024
    [PubMed - indexed for MEDLINE]
Related citations


Impact of Clostridium difficile recurrence on hospital readmissions.
Olsen MA, Yan Y, Reske KA, Zilberberg M, Dubberke ER
Am J Infect Control. 2015 Apr 1; 43(4)318-22. doi: 10.1016/j.ajic.2014.12.020.

PMID:
    25690876
    [PubMed - indexed for MEDLINE]
Related citations


The morbidity, mortality, and costs associated with Clostridium difficile infection.
Kwon JH, Olsen MA, Dubberke ER
Infect Dis Clin North Am. 2015 Mar; 29(1)123-34. doi: 10.1016/j.idc.2014.11.003.

PMID:
    25677706
    [PubMed - indexed for MEDLINE]
Related citations


Recurrent Clostridium difficile infection is associated with increased mortality.
Olsen MA, Yan Y, Reske KA, Zilberberg MD, Dubberke ER
Clin Microbiol Infect. 2015 Feb; 21(2)164-70. doi: 10.1016/j.cmi.2014.08.017.

PMID:
    25658560
    [PubMed - indexed for MEDLINE]
Related citations


Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update.
Dubberke ER, Carling P, Carrico R, Donskey CJ, Loo VG, McDonald LC, Maragakis LL, Sandora TJ, Weber DJ, Yokoe DS, Gerding DN
Infect Control Hosp Epidemiol. 2014 Sep; 35 Suppl 2S48-65.

PMID:
    25376069
    [PubMed]
Related citations


A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates.
Yokoe DS, Anderson DJ, Berenholtz SM, Calfee DP, Dubberke ER, Ellingson KD, Gerding DN, Haas JP, Kaye KS, Klompas M, Lo E, Marschall J, Mermel LA, Nicolle LE, Salgado CD, Bryant K, Classen D, Crist K, Deloney VM, Fishman NO, Foster N, Goldmann DA, Humphreys E, Jernigan JA, Padberg J, Perl TM, Podgorny K, Septimus EJ, VanAmringe M, Weaver T, Weinstein RA, Wise R, Maragakis LL
Infect Control Hosp Epidemiol. 2014 Sep; 35 Suppl 2S21-31.

PMID:
    25376067
    [PubMed]
Related citations


Attributable inpatient costs of recurrent Clostridium difficile infections.
Dubberke ER, Schaefer E, Reske KA, Zilberberg M, Hollenbeak CS, Olsen MA
Infect Control Hosp Epidemiol. 2014 Nov; 35(11)1400-7. doi: 10.1086/678428.

PMID:
    25333435
    [PubMed - indexed for MEDLINE]
Related citations

Notes

Financial Disclosure: Dr. Dubberke’s income from Merck was >$10k in 2014 due to an accounting error by Merck in 2013.  

Areas of Research Interest

Clostridium-difficile infection, infections in transplant and oncology patients